Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'An Interventional, Open-Label, Phase 2 Study to Investigate the Safety and Efficacy of PF-0863440... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the e... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muval... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'GC-LTFU-001: Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells'. The f... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Randomized, Operationally Seamless Phase 2/3 Study to Evaluate the Efficacy and Sa... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Interventional Study of PF-08634404 in Combination with Chemotherapy in Participants wi... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study Evaluating the Effica... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07819409) titled 'Sleep Detection in Residents of Long-term Care Facilities' on Sept. 09. Brief Summary: Sl... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817043) titled 'Microbiology Operations & Time Optimization in Sepsis' on Sept. 08. Brief Summary: The go... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy ... Read More